Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
92.58
+0.83 (0.90%)
At close: Dec 12, 2025, 4:00 PM EST
92.97
+0.39 (0.42%)
After-hours: Dec 12, 2025, 7:56 PM EST

Boston Scientific Revenue

Boston Scientific had revenue of $5.07B in the quarter ending September 30, 2025, with 20.34% growth. This brings the company's revenue in the last twelve months to $19.35B, up 21.62% year-over-year. In the year 2024, Boston Scientific had annual revenue of $16.75B with 17.61% growth.

Revenue (ttm)
$19.35B
Revenue Growth
+21.62%
P/S Ratio
7.07
Revenue / Employee
$365,075
Employees
53,000
Market Cap
137.24B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202416.75B2.51B17.61%
Dec 31, 202314.24B1.56B12.29%
Dec 31, 202212.68B794.00M6.68%
Dec 31, 202111.89B1.98B19.92%
Dec 31, 20209.91B-822.00M-7.66%
Dec 31, 201910.74B912.00M9.28%
Dec 31, 20189.82B775.00M8.57%
Dec 31, 20179.05B662.00M7.89%
Dec 31, 20168.39B909.00M12.16%
Dec 31, 20157.48B97.00M1.31%
Dec 31, 20147.38B237.00M3.32%
Dec 31, 20137.14B-106.00M-1.46%
Dec 31, 20127.25B-373.00M-4.89%
Dec 31, 20117.62B-184.00M-2.36%
Dec 31, 20107.81B-382.00M-4.67%
Dec 31, 20098.19B138.00M1.71%
Dec 31, 20088.05B-307.00M-3.67%
Dec 31, 20078.36B536.00M6.85%
Dec 31, 20067.82B1.54B24.48%
Dec 31, 20056.28B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings